XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
 [1]
Retained Earnings
Total Amdocs Limited Shareholders' Equity
Non-controlling Interests
 [2]
Balance at Sep. 30, 2019 $ 3,542,466 $ 4,452 $ 3,667,662 $ (5,182,409) $ (2,547) $ 5,012,799 $ 3,499,957 $ 42,509
Balance, Shares at Sep. 30, 2019   134,773            
Comprehensive income:                
Net income [2] 497,840         497,840 497,840  
Other comprehensive income (loss) 14,209       14,209   14,209  
Comprehensive income 512,049           512,049  
Employee stock options exercised 97,843 $ 24 97,819       97,843  
Employee stock options exercised, Shares   1,871            
Repurchase of shares (360,912)     (360,912)     (360,912)  
Repurchase of shares, Shares   (5,668)            
Cash dividends declared (168,732)         (168,732) (168,732)  
Issuance of restricted stock, net of forfeitures 7 $ 7         7  
Issuance of restricted stock, net of forfeitures, Shares   559            
Equity-based compensation expense related to employees 42,434   42,434       42,434  
Balance at Sep. 30, 2020 3,665,155 $ 4,483 3,807,915 (5,543,321) 11,662 5,341,907 3,622,646 42,509
Balance, Shares at Sep. 30, 2020   131,535            
Comprehensive income:                
Net income [2] 688,374         688,374 688,374  
Other comprehensive income (loss) (2,324)       (2,324)   (2,324)  
Comprehensive income 686,050           686,050  
Employee stock options exercised 89,058 $ 21 89,037       89,058  
Employee stock options exercised, Shares   1,541            
Repurchase of shares (679,996)     (679,996)     (679,996)  
Repurchase of shares, Shares   (9,036)            
Cash dividends declared (179,344)         (179,344) (179,344)  
Issuance of restricted stock, net of forfeitures 12 $ 12         12  
Issuance of restricted stock, net of forfeitures, Shares   826            
Equity-based compensation expense related to employees 54,249   54,249       54,249  
Balance at Sep. 30, 2021 $ 3,635,184 $ 4,516 3,951,201 (6,223,317) 9,338 5,850,937 3,592,675 42,509
Balance, Shares at Sep. 30, 2021 124,866 124,866            
Comprehensive income:                
Net income [2] $ 549,501         549,501 549,501  
Other comprehensive income (loss) (81,814)       (81,814)   (81,814)  
Comprehensive income 467,687           467,687  
Employee stock options exercised $ 82,909 $ 17 82,892       82,909  
Employee stock options exercised, Shares 1,431 1,431            
Repurchase of shares $ (508,472)     (508,472)     (508,472)  
Repurchase of shares, Shares (6,479) (6,479)            
Cash dividends declared $ (188,852)         (188,852) (188,852)  
Issuance of restricted stock, net of forfeitures 15 $ 15         15  
Issuance of restricted stock, net of forfeitures, Shares   1,024            
Equity-based compensation expense related to employees 71,807   71,807       71,807  
Balance at Sep. 30, 2022 $ 3,560,278 $ 4,548 $ 4,105,900 $ (6,731,789) $ (72,476) $ 6,211,586 $ 3,517,769 $ 42,509
Balance, Shares at Sep. 30, 2022 120,842 120,842            
[1] As of September 30, 2022, 2021 and 2020, accumulated other comprehensive (loss) income is comprised of unrealized (loss) gain on derivatives, net of tax, of $(46,580), $13,773 and $18,836, unrealized loss on short-term interest-bearing investments, net of tax, of $(22,797), $(1,274) and $(2) and unrealized loss on defined benefit plan, net of tax, of $(3,099), $(3,161) and $(7,172).
[2] In fiscal years 2022, 2021 and 2020, all of the Company’s net income is attributable to Amdocs Limited as the net income attributable to the Non-controlling interests is negligible.